Want to join the conversation?
$BCR's sales from Vascular for 4Q15 declined by 2% to $239.3MM from last year, while Urology sales remained virtually unchanged at $217.9MM. Sales from Surgical Specialties increased by 5% to $152.8MM and Oncology sales rose slightly to $237.8MM from $237.5MM.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.